Skip to content
newsechoasia

newsechoasia

Press Releases, Companye Events, Business News in Asia

Menu
  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Finance
  • Business
  • Instant
  • Contact

Tag: trials

Posted onFebruary 15, 2023

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials,…

Read More
Posted onFebruary 8, 2023

Fuel Cell Bus Trials on the BRT Hikoboshi Line

TOKYO, Feb 8, 2023 – (JCN Newswire via SEAPRWire.com) – Fukuoka Prefecture, Commercial Japan Partnership Technologies Corporation (CJPT), and Kyushu Railway Company (JR Kyushu) have…

Read More
Posted onFebruary 3, 2023

Asia Pacific Cell & Gene Research: Novotech is Growing 50% Faster than ROW

SYDNEY, AU, Feb 3, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia…

Read More
Posted onDecember 20, 2022

Novotech is Gold Sponsor at Biotech Showcase 2023

SYDNEY, AU, Dec 20, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor…

Read More
Posted onDecember 15, 2022

Data Shows 50% of New Trials Have Sites in Asia Pacific

SYDNEY, AU, Dec 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication…

Read More
Posted onNovember 11, 2022

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

SYDNEY, AU, Nov 11, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022,…

Read More
Posted onOctober 7, 2022

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

SYDNEY, AU, Oct 7, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global…

Read More
Posted onSeptember 15, 2022

Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference

SYDNEY, AU, Sep 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell &…

Read More
Posted onSeptember 5, 2022

Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC

SYDNEY, Sep 5, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new…

Read More
Posted onSeptember 2, 2022

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a…

Read More
Posted onJuly 25, 2022

Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award 2022”

SYDNEY, Jul 25, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has…

Read More
Posted onJune 29, 2022

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

SEOUL, S.KOREA, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services…

Read More
Posted onJune 23, 2022

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

CHICAGO, IL, Jun 23, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services…

Read More
Posted onJune 15, 2022

Novotech’s APAC and USA Leadership Teams at BIO 2022

SAN DIEGO, CA, Jun 14, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its…

Read More
Posted onJune 6, 2022

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

SYDNEY, Jun 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to…

Read More
Posted onJune 6, 2022

NTT DOCOMO and NTT to Collaborate on 6G Experimental Trials with World-leading Mobile Technology Vendors

TOKYO, Jun 6, 2022 – (JCN Newswire via SEAPRWire.com) – NTT DOCOMO, INC. (DOCOMO) and Nippon Telegraph and Telephone Corporation (NTT) announced today that they…

Read More
Posted onJune 6, 2022

Fujitsu, NTT DOCOMO and NTT to start joint trials towards practical applications for 6G

TOKYO, Jun 6, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced that it will start collaboration with NTT DOCOMO, INC. (hereinafter DOCOMO)(1) and…

Read More
Posted onJune 2, 2022

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US

SYDNEY, Jun 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to…

Read More
Posted onMay 12, 2022

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

SYDNEY, May 12, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services…

Read More
Posted onApril 19, 2022

Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC

ADELAIDE, AUS, Apr 19, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has…

Read More

Posts navigation

Page 1 Page 2 Next Page

目录导航

  • 首页
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • 商业新闻
  • 财经新闻
  • 即时热闻
  • 联络我们
  • 关于我们
  • RSS

Singapore News

  • 特朗普援引丘吉尔及“特殊关系”,正值英国言论自由受质疑日益增多 September 17, 2025
  • 西班牙首相因涉嫌对以色列发出核威胁引发众怒 September 17, 2025
  • 南美国家因柴油价格上涨爆发暴力抗议,全国宣布进入紧急状态 September 17, 2025
  • 值得关注的顶级AI股票 September 17, 2025
  • 香港董事学会的《施政报告》回应 经济虽在转型 机会大于挑战 September 17, 2025
  • GMG Launches First to Market Multi Language Global Graphene Enhanced Product Range for Distributors September 17, 2025
  • 克鲁兹抨击联合国对以色列的“种族灭绝”指控,推动追究责任 September 17, 2025
  • Casa Minerals Inc Announces Advanced Ground IP Survey at the Arsenault Project September 17, 2025
  • Definitive agreement to implement a joint mine plan between Los Bronces and Andina copper mines September 17, 2025
  • Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches ‘Global Open Innovation’ for U.S. Startups September 17, 2025
  • Anti-MTBR (microtubule binding region) Tau Antibody Etalanetug Granted FDA Fast Track Designation September 17, 2025
  • HKTDC welcomes 2025 Policy Address September 17, 2025
  • BestStock.ai unveils autonomous AI for real-time market analysis and predictive modeling September 17, 2025
  • Honda Announces New Electric Motorcycle “Honda WN7” in Europe September 17, 2025
  • 东吴水泥苏州国资入主 绘就港苏协同新蓝图 September 17, 2025

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
© Copyright 2024 – NewsEchoAsia